For the first time, scientists have invented a liquid ink that doctors can print onto a patient’s scalp to measure brain activity. The technology, presented December 2 in the Cell Press journal Cell Biomaterials, offers a promising alternative to the cumbersome process currently used for monitoring brainwaves and diagnosing neurological conditions. It also has the potential to enhance non-invasive brain-computer interface applications.
Novel intermediate form of serotonin receptor identified as therapeutic target for psychiatric disorders
Misha Kudryshev’s lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression
September 4, 2024